Trisomy 21
– Down syndrome
The most common chromosomal abnormality, associated with intellectual disability and congenital developmental disorders.
NIFTY analyses the baby's DNA from the mother's blood and helps detect the most common chromosomal and genetic abnormalities from the 10th week of pregnancy.
The most common chromosomal abnormality, associated with intellectual disability and congenital developmental disorders.
A serious genetic condition associated with developmental complications and a high risk of health problems.
A rare genetic condition with serious developmental consequences.
Depending on the type of test, NIFTY can also analyse:

Some genetic conditions can be passed on silently from parents to their child without the parents knowing.
NIFTY MONO AR makes it possible to test the mother for carrier status of selected autosomal recessive conditions during pregnancy.

One of the most common inherited genetic conditions in Europe, affecting mainly the respiratory and digestive systems.

A rare genetic condition associated with impaired development, growth and metabolism.
If both parents are carriers of the condition:

Not all genetic tests detect the same number of genetic variants. The scope of the test can significantly affect its diagnostic accuracy.

For cystic fibrosis and SLOS, NIFTY MONO AR does not test the fetus directly for the condition; it is a carrier screening of the mother.
If the mother is confirmed to be a carrier, the father's genetic status also needs to be known in order to assess the risk for the child.
Even when both parents are found to be carriers, this is not yet a diagnosis of the specific fetus.

More than 1,000 pathogenic variants are known in the CFTR gene.
Available tests examine:
– only the F508del variant – approximately 70% of cystic fibrosis cases in the European population,
– a panel of the 31 most common variants – approximately 85 – 90% of cases,
– sequencing of the entire CFTR gene – coverage of almost 100% of known pathogenic variants.

Approximately 120 pathogenic variants are known in the DHCR7 gene.
Some basic panels examine only selected variants and may miss some common cases of the condition.
Sequencing of the entire DHCR7 gene provides high diagnostic certainty, as it can also identify rare or newly discovered pathogenic variants.

Sequencing of the entire gene significantly increases the detection rate, but some large deletions or structural variants may require additional genetic testing with specific methods (e.g. MLPA).
The complete lists for NIFTY MONO AR, NIFTY MONO AD and NIFTY MAX will be added soon.
For twins, NIFTY Basic, NIFTY PRO and NIFTY MONO AR are available (NIFTY PRO 98 + maternal carrier test for 172 conditions). You can compare all tests on the Test types page.
Write to us and we will get back to you as soon as possible.
We will get back to you as soon as possible. If it is urgent, call us on +421 915 842 336.